| Q83969970 | Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study |
| Q38805239 | Age and Sex Distributions of Age-Related Biomarker Values in Healthy Older Adults from the Long Life Family Study. |
| Q36046811 | Age, Gender and Load-Related Influences on Left Ventricular Geometric Remodeling, Systolic Mid-Wall Function, and NT-ProBNP in Asymptomatic Asian Population |
| Q43805095 | Amino-terminal pro-brain natriuretic peptid in prediction of left ventricular ejection fraction. |
| Q48409814 | Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure |
| Q48030178 | Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure |
| Q47970134 | Assessing the hydration status of children with chronic kidney disease and on dialysis: a comparison of techniques. |
| Q51098383 | Association of Lead aVR T-wave Amplitude With Cardiovascular Events or Mortality Among Prevalent Dialysis Patients. |
| Q48383897 | Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure |
| Q49158614 | B-type natriuretic peptide and its precursor in cardiac venous blood from failing hearts |
| Q39408913 | Cardiac and Carotid Markers Link With Accelerated Brain Atrophy: The AGES-Reykjavik Study (Age, Gene/Environment Susceptibility-Reykjavik). |
| Q92776906 | Cardio-Oncology at the Beginning of a New Decade |
| Q64097355 | Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adults |
| Q37477161 | Correlation between levels of N-terminal pro-B-type natriuretic peptide and degrees of heart failure |
| Q36232775 | Cost-effective strategies to screen for left ventricular systolic dysfunction in the community--a concept |
| Q33816471 | Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients |
| Q37869225 | Defining characteristics of decreased cardiac output: a literature review |
| Q39378973 | Diagnosis and therapy for diastolic heart failure |
| Q37411609 | Diagnostic Utility of ANG in Coronary Heart Disease Complicating Chronic Heart Failure: A Cross-Sectional Study |
| Q48453082 | Global left ventricular longitudinal strain is closely associated with increased neurohormonal activation after acute myocardial infarction in patients with both reduced and preserved ejection fraction: a two-dimensional speckle tracking study |
| Q40232884 | Hyponatraemia at hospital admission is a predictor of overall mortality |
| Q88551094 | Letter to the Editor: A Prospective Comparative Study on Improvement of Hyperthyroid Cardiovascular Dysfunction in Patients Undergoing Total Thyroidectomy Versus Medical Management |
| Q48631855 | NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy |
| Q36861287 | Nonheart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis |
| Q45110914 | Pentraxin-3 level at admission is a strong predictor of short-term mortality in a community-based hospital setting |
| Q48668758 | Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study |
| Q37352819 | ProANP plasma measurement predicts all-cause mortality in acutely hospitalised patients: a cohort study |
| Q34381858 | Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT Trial |
| Q35161498 | Relationship between N-terminal pro-B-type natriuretic peptide and renal function: the effects on predicting early outcome after off-pump coronary artery bypass surgery |
| Q37488984 | Relationship between Serum N-Terminal Pro-Brain Natriuretic Peptide Level and Left Ventricular Dysfunction and Extracellular Water in Continuous Ambulatory Peritoneal Dialysis Patients |
| Q33740059 | Risk stratification in emergency patients by copeptin |
| Q36694171 | Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease |
| Q35574253 | Screening for left ventricular dysfunction in the community: role of hand held echocardiography and brain natriuretic peptides |
| Q48881144 | Serum levels of natriuretic peptides in children with various types of loading conditions |
| Q37313438 | Some heterogeneity factors affecting the B-type natriuretic peptides outcome: a meta-analysis |
| Q89777728 | Standard measures for sickle cell disease research: the PhenX Toolkit sickle cell disease collections |
| Q43457825 | The NT-proBNP assay identifies very elderly nursing home residents suffering from pre-clinical heart failure |
| Q43834139 | The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality |
| Q37972865 | Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies |
| Q48030186 | Use of NT-proBNP in routine testing and comparison to BNP. |
| Q30908639 | Value of N-terminal pro brain natriuretic peptide in the elderly: data from the prospective Copenhagen Hospital Heart Failure study (CHHF). |
| Q39298369 | What role does the stress response have in congestive heart failure? |